Knight Therapeutics Inc:
* KNIGHT THERAPEUTICS REPORTS FIRST QUARTER 2020 RESULTS
* KNIGHT THERAPEUTICS INC - QTRLY BASIC NET LOSS PER SHARE $0.01 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.
Knight Therapeutics Inc:
* KNIGHT THERAPEUTICS INC - QTRLY BASIC NET LOSS PER SHARE $0.01 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.